Simvastatin, a pharmaceutical agent that is clinically prescribed for lowering blood lipids, has been shown in early experiments to be an effective inhibitor of TGF‐β1‐induced proliferation of type I collagen and CTGF in keloid fibroblasts [1]. The gene discussed is TGFB1; the disease is keloid.